These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 3791273)

  • 1. Phase II evaluation of mitoguazone in metastatic hormone-resistant prostate cancer: a Southeastern Cancer Study Group trial.
    Moore MR; Graham SD; Birch R; Irwin L
    Cancer Treat Rep; 1987 Jan; 71(1):89-90. PubMed ID: 3791273
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase II evaluation of weekly cisplatin in metastatic hormone-resistant prostate cancer: a Southeastern Cancer Study Group Trial.
    Moore MR; Troner MB; DeSimone P; Birch R; Irwin L
    Cancer Treat Rep; 1986 Apr; 70(4):541-2. PubMed ID: 3698053
    [No Abstract]   [Full Text] [Related]  

  • 3. Phase II evaluation of mitoguazone in cancers of the esophagus, stomach, and pancreas: a Southeastern Cancer Study Group Trial.
    Ravry MJ; Omura GA; Hill GJ; Bartolucci AA; Velez-Garcia E
    Cancer Treat Rep; 1986 Apr; 70(4):533-4. PubMed ID: 3698050
    [No Abstract]   [Full Text] [Related]  

  • 4. Mitoguazone in advanced squamous cell carcinoma of head and neck origin: a phase II trial of the Southeastern Cancer Study Group.
    Luedke DW; Maddox W; Birch R; Velez-Garcia E; Schleuter J
    Cancer Treat Rep; 1986 Apr; 70(4):529-30. PubMed ID: 3698048
    [No Abstract]   [Full Text] [Related]  

  • 5. Phase II trial of mitoguazone in patients with refractory germ cell tumors.
    Chun H; Bosl GJ
    Cancer Treat Rep; 1985 Apr; 69(4):461-2. PubMed ID: 2986835
    [No Abstract]   [Full Text] [Related]  

  • 6. Phase II study of mitoguazone in pancreatic cancer: a Southwest Oncology Group Study.
    Inamasu MS; Oishi N; Chen TT; Kraut EH; Grozea PN; Costanzi JJ; Bonnet JD
    Cancer Treat Rep; 1986 Apr; 70(4):531-2. PubMed ID: 3698049
    [No Abstract]   [Full Text] [Related]  

  • 7. Phase II trial of mitoguazone in patients with advanced head and neck cancer.
    Thongprasert S; Bosl GJ; Geller NL; Wittes RE
    Cancer Treat Rep; 1984 Oct; 68(10):1301-2. PubMed ID: 6525604
    [No Abstract]   [Full Text] [Related]  

  • 8. Methyl-GAG in advanced colon cancer: a phase II trial of the Southwest Oncology Group.
    Knight WA; Loesch DM; Leichman LP; Fabian C; O'Bryan RM
    Cancer Treat Rep; 1982 Dec; 66(12):2099-100. PubMed ID: 7139653
    [No Abstract]   [Full Text] [Related]  

  • 9. Results of a Dutch Phase II trial with the LHRH agonist buserelin in patients with metastatic prostatic cancer.
    Debruyne FM; Karthaus HF; Schröder FH; de Voogt HJ; de Jong FH; Klijn JG
    Prog Clin Biol Res; 1985; 185A():251-70. PubMed ID: 3929265
    [No Abstract]   [Full Text] [Related]  

  • 10. Methylglyoxal-bis(guanylhydrazone) in hormone-resistant adenocarcinoma of the prostate.
    Scher HI; Yagoda A; Ahmed T; Watson RC
    J Clin Oncol; 1985 Feb; 3(2):224-8. PubMed ID: 3968552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitoguazone in advanced renal carcinoma: a phase II trial of the Southwest Oncology Group.
    Knight WA; Drelichman A; Fabian C; Bukowski RM
    Cancer Treat Rep; 1983 Dec; 67(12):1139-40. PubMed ID: 6652631
    [No Abstract]   [Full Text] [Related]  

  • 12. Phase II study of spirogermanium in metastatic prostate cancer.
    Dexeus FH; Logothetis C; Samuels ML; Hossan B
    Cancer Treat Rep; 1986 Sep; 70(9):1129-30. PubMed ID: 3742495
    [No Abstract]   [Full Text] [Related]  

  • 13. Phase II trial of methyl-GAG in advanced renal cancer.
    Zeffren J; Yagoda A; Watson RC; Natale RB; Blumenreich MS; Chapman R; Howard J
    Cancer Treat Rep; 1981; 65(5-6):525-7. PubMed ID: 6263478
    [No Abstract]   [Full Text] [Related]  

  • 14. Phase II evaluation of methyl-GAG in patients with refractory metastatic breast cancer.
    Yap HY; Blumenschein GR; Schell F; Bodey GP
    Cancer Treat Rep; 1981; 65(5-6):465-7. PubMed ID: 7237467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II trial of mitoguazone in children with leukemia and lymphoma: a Pediatric Oncology Group Study.
    Kinney TR; Krischer JP; Starling KA; Alvarado C; Kamen B
    Cancer Treat Rep; 1986 Aug; 70(8):1041-2. PubMed ID: 3524835
    [No Abstract]   [Full Text] [Related]  

  • 16. Phase II trial of mitoguazone in patients with relapsed small cell carcinoma of the lung.
    Scher H; Chapman R; Kelsen D; Gralla R; Wittes R
    Cancer Treat Rep; 1984 Mar; 68(3):561-2. PubMed ID: 6322989
    [No Abstract]   [Full Text] [Related]  

  • 17. Phase II trial of methyl-G (methylglyoxal bis-guanylhydrazone) in patients with metastatic renal cell carcinoma.
    Fuks JZ; Van Echo DA; Aisner J; Mitchell EP; Woolley PV; Wiernik PH
    Cancer Clin Trials; 1981; 4(4):411-4. PubMed ID: 7318123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. European Organization for Research and Treatment of Cancer (EORTC) phase II study of low-dose weekly epirubicin in metastatic prostate cancer.
    Jones WG; Fosså SD; Bono AV; Klijn JG; De Pauw M; Sylvester R
    Cancer Treat Rep; 1987 Dec; 71(12):1317-8. PubMed ID: 3480046
    [No Abstract]   [Full Text] [Related]  

  • 19. Phase II trial of mitoguazone in patients with advanced squamous cell carcinoma of the head and neck.
    Perry DJ; Crain SM; Weltz MD; Wilson JP; Davis RK; Woolley PV; Forastiere AA; Taylor HG; Weiss RB
    Cancer Treat Rep; 1983 Jan; 67(1):91-2. PubMed ID: 6616496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I-II trial of methyl-GAG in advanced colon cancer. a Southwest Oncology Group pilot study.
    Myers JW; Knight WA; Livingston RB; Fabian C; Costanzi J
    Cancer Clin Trials; 1981; 4(3):277-9. PubMed ID: 7285275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.